Exercise echo may catch silent heart failure in rare HHT liver disease
NCT ID NCT05954481
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed pilot study looked at 47 adults with hereditary hemorrhagic telangiectasia (HHT) who also have liver involvement. Researchers used exercise echocardiography (heart ultrasound while pedaling) to measure lung artery pressure during exercise. The goal was to see if this test could detect early signs of heart failure before they show up at rest, potentially helping doctors decide when to consider advanced treatments like liver transplantation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stress echocardiography
- What this could lead to
- If successful, this could lead to earlier detection of heart failure in HHT patients, potentially improving timing for treatments like liver transplantation.
- What could go wrong
- This is a small pilot study with only 47 participants, so results may not apply to all patients. It is observational and does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HEMORRHAGIC TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service Explorations fonctionnelles cardiovasculaires - Hôpital Louis Pradel
Bron, 69677, France
-
Service génétique - Hôpital Femme Mère Enfant
Bron, 69677, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A pill to stop the bleeding? new hope for HHT nosebleeds
- Massive HHT registry aims to unlock secrets of rare bleeding disorder
- Blood thinners in HHT: a risky balancing act under the microscope
- Can a transplant drug stop HHT nosebleeds? small study tests sirolimus
- New antibody aims to tame rare bleeding disorder
- New drug aims to stop nosebleeds in rare blood vessel disorder